ArticlePLoS genetics2013

An evolutionarily conserved synthetic lethal interaction network identifies FEN1 as a broad-spectrum target for anticancer therapeutic development.

Derek M van Pel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.